The world-renowned transformative medicine expert will contribute towards Mind Cure's work in the realm of psychedelic research, treatment and integration
The world-renowned transformative medicine expert will contribute towards Mind Cure's work in the realm of psychedelic research, treatment and integration
Mind Cure's new Chief Operating Officer has already launched several successful businesses.
The company bolsters its executive team with the addition of an industry leader and experienced entrepreneur
Psychedelic stocks have exploded on news of the Compass Pathways IPO. Three companies are leading the charge.
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
Mind Cure adds a health supplements veteran to its product development team. Moonbeam mushrooms in final product testing.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now